| Lineage |
iPSC > Neural Progenitor > Spinal Cord Organoid > Motor Neuron |
| Markers |
HB9 (MNX1), ISL1, CHAT, TAChE, SMI-32, NF |
| Brain Regions |
Spinal Cord - Ventral Horn |
| Disease Relevance |
Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Polio |
Spinal Cord Organoid Motor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Spinal cord organoid motor neurons are in vitro generated motor neurons within three-dimensional spinal cord organoid cultures. These neurons express the definitive motor neuron marker HB9 (MNX1), form functional neuromuscular junctions with co-cultured muscle cells, and model the ventral horn of the human spinal cord[1][2].
Motor neuron differentiation mimics spinal cord development:
- Neural tube induction: Dual-SMAD inhibition (SB431542, LDN-193189)
- Ventral patterning: SHH and retinoic acid specify motor neuron fate
- Motor neuron progenitors: Expression of OLIG2, NKX6.1
- Post-mitotic motor neurons: HB9, ISL1 expression
- Maturation: Process extension, neurotransmitter synthesis
- SHH: Ventralizing signal
- Retinoic Acid: Rostro-caudal patterning
- BDNF: Neuronal survival
- GDNF: Axonal outgrowth
- cAMP: Neurotransmitter synthesis
Large neurons innervating extrafusal muscle fibers:
- Function: Voluntary movement
- Markers: Nissl substance, neurofilament
- Most affected in ALS
Small neurons innervating intrafusal muscle fibers:
- Function: Muscle spindle control
- Markers: ER81
Mixed innervation pattern:
¶ Sporadic and Familial ALS
Spinal organoid motor neurons from ALS patients model:
- TDP-43 proteinopathy (95% of ALS cases)
- SOD1 mutations (familial ALS)
- C9orf72 hexanucleotide repeat expansion
- FUS mutations
- Progressive axonal degeneration
- Mitochondrial dysfunction
- Excitotoxicity[^3]
- Reduced neuronal survival
- Dysregulated RNA metabolism
- Impaired autophagy
- Elevated oxidative stress
- Synaptic dysfunction
- Riluzole (approved)
- Edaravone (approved)
- Experimental compounds targeting:
- Protein aggregation
- Mitochondrial function
- Neuroinflammation
- RNA metabolism
SMA patient-derived motor neurons exhibit:
- Reduced SMN protein levels
- Impaired splicing
- Axonal growth defects
- Synaptic dysfunction
- Vulnerability to degeneration[^4]
- Antisense oligonucleotides (ASOs)
- SMN-enhancing small molecules
- Gene therapy approaches
- Action potentials with large amplitudes
- Current-induced firing
- Neuromuscular junction formation
- Spontaneous bursting activity
- Activity-dependent survival
Motor neurons form functional NMJs with:
- Primary human muscle cells
- iPSC-derived muscle myotubes
- 3D muscle constructs
Engineered platforms for:
- Directed axon growth
- Quantified NMJ formation
- Synaptic transmission recording
The study of Spinal Cord Organoid Motor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Maury et al., Derivation of spinal cord motor neurons from human pluripotent stem cells (2015)
- Du et al., Spinal cord organoids from human pluripotent stem cells (2019)
- Bursch et al., ALS iPSC models: progress and challenges (2019)
- Lefebvre et al., SMN deficiency causes motor neuron degeneration in SMA (2018)
- Kanning et al., Motor neuron diversity in development and disease (2019)